Acute Myocarditis Related to COVID-19: Comparison to SARS and MERS

Angeliki M Chasouraki1, Odyssefs A Violetis1, Mahmoud Abdelrasoul1

  • 1Internal Medicine Clinic, Pammakaristos Hospital of Divine Providence (Reference Centre for COVID-19 infection), Iakovaton 43, 11144 Athens, Greece.

Insights

Severe COVID-19 infection can impact the heart, with myocardial injury observed in up to 30% of patients. This review examines potential myocarditis cases linked to SARS-CoV-2, comparing them with prior coronavirus outbreaks.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • Previous outbreaks of SARS and MERS demonstrated myocardial involvement.
  • SARS-CoV-2 (COVID-19) infection presents a spectrum of severity, from asymptomatic to critical multi-system disease.
  • Cardiac complications, particularly myocardial injury, are increasingly recognized in severe COVID-19.

Purpose of the Study:

  • To review and analyze reported cases of myocarditis associated with SARS-CoV-2 infection.
  • To compare the clinical presentation, treatment, and prognosis of COVID-19-related myocarditis with findings from SARS and MERS outbreaks.
  • To assess the evidence for direct myocardial involvement in SARS-CoV-2 infection.

Main Methods:

  • Literature review of cases describing myocarditis in COVID-19 patients.
  • Comparative analysis with existing literature on myocardial involvement in SARS and MERS.
  • Evaluation of clinical data, diagnostic markers (e.g., myocardial enzymes), and outcomes.

Main Results:

  • Myocardial injury, indicated by elevated cardiac enzymes, affects up to 30% of COVID-19 patients, correlating with poorer prognosis.
  • Evidence for direct SARS-CoV-2 myocardial involvement in myocarditis cases is variable.
  • Comparison with SARS and MERS suggests potential similarities in cardiac manifestations.

Conclusions:

  • Myocardial involvement is a significant concern in severe COVID-19.
  • Further research is needed to elucidate the mechanisms and clinical implications of SARS-CoV-2-induced myocarditis.
  • Understanding cardiac involvement in COVID-19 is crucial for patient management and prognosis, drawing parallels from previous coronavirus studies.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
118
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
184
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
86
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
116
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
221
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
152